Ask AI
Oral SERDs A Step Forward

CME

Oral SERDs in HR+/HER2- Breast Cancer: A Step Forward in Precision Endocrine Therapy

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: November 17, 2025

Expiration: May 16, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

If FDA approved or included in guidelines, how likely would you be to use an oral SERD in combination with a CDK4/6 inhibitor?